Salary after B.Pharm & M.Pharm | Top Pharma Companies for Good Salary

Описание к видео Salary after B.Pharm & M.Pharm | Top Pharma Companies for Good Salary

In this video, I am going to share the salary details that pharma companies offer to B.Pharm and M.Pharm freshers.

#salaryafterbpharm #salaryaftermpharm #pharmarevolution

List of Top Pharma Companies for better career growth.

✔Sun Pharmaceutical Industries Ltd.
✔Cipla Ltd.
✔Dr. Reddy's Laboratories Ltd.
✔Torrent Pharmaceuticals Ltd.
✔Biocon Ltd.
✔Alkem Laboratories Ltd.
✔Aurobindo Pharma Ltd.
✔Abbott India Ltd.
✔Novartis India Ltd.
✔Zydus Lifesciences Ltd.
✔Lupin Ltd.
✔GlaxoSmithKline Pharmaceuticals Ltd.
✔Ipca Laboratories Ltd.
✔Syngene International Ltd.
✔Pfizer Ltd.
✔Alembic Pharmaceuticals Ltd.
✔Ajanta Pharma Ltd.
✔Glenmark Pharmaceuticals Ltd.
✔JB Chemicals & Pharmaceuticals Ltd.
✔AstraZeneca Pharma India Ltd.
✔FDC Ltd.
✔Wockhardt Ltd.
✔Strides Pharma Science Ltd.
✔Unichem Laboratories Ltd.

----------------------------------------------------------------------------------------------------------------
Hello! I am Ashutosh Kumar Srivastava, Founder of Pharma-Revolution, A GMP Trainer, and a Career Coach.
----------------------------------------------------------------------------------------------------------------
Pharma Revolution is India's First Online Career Platform for Pharmacy Students and Professionals.

Career Guidance: Visit www.pharma-revolution.com

Career Start: Visit https://www.pharma-revolution.com/car...

--------------------------------------------------------------------------------------------------------
✔LINKEDIN: @pharmarevolution
  / admin  

✔FACEBOOK: @pharmarevolution
  / pr3333  

✔INSTAGRAM: @pharmarevolution
  / pharmarevolution  

----------------------------------------------------------------------------------------------------

-----------------------------------------------------------------------------------------------------
NOTE: All content used is copyright to Pharma-Revolution,
Use or commercial display or editing of the content without proper
authorization is not allowed.

Комментарии

Информация по комментариям в разработке